Navigation Links
Brennen Medical Announces Sale of XenMatrix(R)
Date:9/21/2009

ST. PAUL, Minn., Sept. 21 /PRNewswire/ -- Brennen Medical, LLC, a leader in biomaterials technology, announces the sale of its XenMatrix(R) device to Davol Inc., a subsidiary of C.R. Bard, Inc. The agreement provides Davol with the worldwide rights and related assets of the hernia products business of Brennen Medical, LLC. This acquisition includes technology for a non crosslinked xenograft device for use in soft tissue repair including hernia and abdominal wall reconstruction.

XenMatrix employs a proprietary technology that maintains an acellular structurally intact, non crosslinked porcine dermal matrix for enhanced biocompatibility in host tissue. This dermal matrix supports revascularization, remodeling and regeneration for abdominal wall and hernia repairs. Recently published data in the American Journal of Surgery from the Brigham and Women's Hospital studied the use of XenMatrix in complex abdominal wall defects and reported a 93% success rate with over 16 months follow-up.

"We are extremely pleased with the successful clinical outcomes of XenMatrix. Now with the acquisition by C.R. Bard, this product will reach a far greater number of patients worldwide, who will truly benefit from this device," said Phillip Lawin, PhD, President of Brennen Medical.

About Brennen Medical, LLC

Brennen Medical is a world leader providing biologic porcine xenograft for use in plastic reconstructive, general surgery, burn, trauma, wound, urogynecological and orthopedic soft tissue repair procedures. Demonstrated to be effective, surgeons have used Brennen's proprietary porcine technologies for over 40 years. Mediskin(R) and EZ Derm(R), XenMatrix and DermMatrix(R) provide the basis for innovation and quality to guide the Company's initiatives for a growing biosurgical market. Based in St. Paul, MN and privately held, the products are sold through a direct sales force and through partnerships with major medical device companies. In addition to porcine, Brennen also markets a line of products containing oat beta glucan, a natural complex carbohydrate successfully used to manage burn and chronic wounds.

XenMatrix and DermMatrix are trademarks and/or registered trademarks of C. R. Bard, Inc. or an affiliate.

Mediskin and EZ Derm are registered trademarks of Brennen Medical, LLC.


'/>"/>
SOURCE Brennen Medical, LLC
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. AEterna Zentaris completes management team with the appointment of Chief Medical Officer
2. VisEn Medical Files Action to Invalidate New Caliper Life Sciences Patent
3. China Medical Technologies to Participate in the Morgan Stanleys 2007 China Medical Corporate Day
4. Pathway Medical Technologies Adds Joe Rafferty as VP, Sales, and Moves To Larger Facility to Accommodate Rapid Growth
5. BioMS Medical announces its intention to renew a normal course issuer bid
6. Dr. Amit Dhawan Promoted to Medical Director for The Mattson Jack Group
7. ATS Medical Expands Open Pivot Heart Valve Offerings
8. AGA Medical Corporation Receives FDA and CE Mark Approvals for the AMPLATZER Vascular Plug II
9. Globus Medical Announces Record 2nd Quarter 2007 Results
10. IDM Pharma Names Dr. Jeffrey W. Sherman Chief Medical Officer and Senior Vice President of Research and Development
11. China Medical Technologies Reports First Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2016)... , ... May 24, 2016 , ... ... diabetes, and traumatic injuries, will be accelerated by research at Worcester Polytechnic Institute ... engines of wound healing and tissue regeneration. , The novel method, developed by ...
(Date:5/24/2016)... La Jolla, CA (PRWEB) , ... May 24, 2016 , ... ... and financial planning for corporate executives and entrepreneurs, held The Future of San Diego ... leaders in the San Diego life science community attended the event with speakers Dr. ...
(Date:5/23/2016)... ... ... blood donations in South Texas and across the nation is growing. , But according to ... are on the decline. In fact, donations across the country are at their lowest point ... the last four years alone. , There is no substitute for blood. , “We want ...
(Date:5/23/2016)... , May 23, 2016 Zimmer Biomet Holdings, ... healthcare, today announced that its Board of Directors has approved ... the second quarter of 2016. The cash ... about July 29, 2016 to stockholders of record as of ... of dividends are subject to approval of the Board of ...
Breaking Biology Technology:
(Date:4/19/2016)... , UAE, April 20, 2016 ... be implemented as a compact web-based "all-in-one" system solution ... the biometric fingerprint reader or the door interface with ... of modern access control systems. The minimal dimensions of ... ID readers into the building installations offer considerable freedom ...
(Date:4/15/2016)... Research and Markets has announced ... 2016-2020,"  report to their offering.  , ... global gait biometrics market is expected to grow ... 2016-2020. Gait analysis generates multiple variables ... to compute factors that are not or cannot ...
(Date:4/13/2016)... physicians supporting Medicaid patients in Central Florida ... telehealth thanks to a new partnership with higi.   ... can routinely track key health measurements, such as blood ... they opt in, share them with IMPOWER clinicians through ... location at no cost. By leveraging this data, IMPOWER ...
Breaking Biology News(10 mins):